secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK:        0000949858
Form:       8-K
Filed at:   2022-03-15T23:59:59+00:00
Accession:  0001564590-22-010148
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Achieve Life Sciences appoints Vaughn Himes, PhD to Board of Directors
----------------------------------------------------------------------

- Dr. Himes appointed as director effective March 14, 2022; no committee assignment yet.
- Annual cash retainer of $40,000 for Board service.
- Initial option grant for 6,600 shares, vesting monthly over 36 months, exercise price at Nasdaq close on grant date.
- No arrangements, family relationships, or material interests per Item 404(a) reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/949858/000156459022010148/0001564590-22-010148-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/949858/000156459022010148/achv-8k_20220308.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-010148

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer